Search by Drug Name or NDC

    NDC 75834-0289-25 Phenobarbital Sodium 130 mg/mL Details

    Phenobarbital Sodium 130 mg/mL

    Phenobarbital Sodium is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is PHENOBARBITAL SODIUM.

    Product Information

    NDC 75834-0289
    Product ID 75834-289_dc20c3e0-8253-4ad6-9e19-b69ea2f11a2e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Phenobarbital Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Phenobarbital Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 130
    Active Ingredient Units mg/mL
    Substance Name PHENOBARBITAL SODIUM
    Labeler Name Nivagen Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule CIV
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2022-12-31

    Package

    NDC 75834-0289-25 (75834028925)

    NDC Package Code 75834-289-25
    Billing NDC 75834028925
    Package 25 VIAL in 1 BOX (75834-289-25) / 1 mL in 1 VIAL (75834-289-01)
    Marketing Start Date 2021-09-15
    NDC Exclude Flag N
    Pricing Information N/A